These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22353235)

  • 1. Reversal of SSRI-associated apathy syndrome by discontinuation of therapy.
    Padala PR; Padala KP; Monga V; Ramirez DA; Sullivan DH
    Ann Pharmacother; 2012 Mar; 46(3):e8. PubMed ID: 22353235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors-associated apathy syndrome: A cross sectional study.
    Padala PR; Padala KP; Majagi AS; Garner KK; Dennis RA; Sullivan DH
    Medicine (Baltimore); 2020 Aug; 99(33):e21497. PubMed ID: 32871995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.
    Raskin J; George T; Granger RE; Hussain N; Zhao GW; Marangell LB
    J Psychiatr Res; 2012 May; 46(5):667-74. PubMed ID: 22410206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.
    van Geffen EC; Hugtenburg JG; Heerdink ER; van Hulten RP; Egberts AC
    Eur J Clin Pharmacol; 2005 Jun; 61(4):303-7. PubMed ID: 15906018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson's disease?
    Zahodne LB; Bernal-Pacheco O; Bowers D; Ward H; Oyama G; Limotai N; Velez-Lago F; Rodriguez RL; Malaty I; McFarland NR; Okun MS
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):326-30. PubMed ID: 23037646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants for Depression, Apathy, and Gait Instability in Parkinson's Disease: A Multicenter Randomized Study.
    Takahashi M; Tabu H; Ozaki A; Hamano T; Takeshima T;
    Intern Med; 2019 Feb; 58(3):361-368. PubMed ID: 30146591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials.
    Guo S; Chen L; Cheng S; Xu H
    Medicine (Baltimore); 2019 May; 98(22):e15786. PubMed ID: 31145302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apathy syndrome in depressed patients previously treated with selective serotonin reuptake inhibitors].
    Petrova NN; Markin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):111-117. PubMed ID: 32105278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyponatremia associated with sertraline and fluoxetine: a case report.
    Raphael K; Tokeshi J
    Hawaii Med J; 2002 Mar; 61(3):46-7. PubMed ID: 11965835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder.
    Rothschild AJ; Raskin J; Wang CN; Marangell LB; Fava M
    Compr Psychiatry; 2014 Jan; 55(1):1-10. PubMed ID: 24268564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of akathisia induced by escitalopram: case report & review of literature.
    Basu B; Gangopadhyay T; Dutta N; Mandal B; De S; Mondal S
    Curr Drug Saf; 2014 Mar; 9(1):56-9. PubMed ID: 24568368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delirium Associated With Fluoxetine Discontinuation: A Case Report.
    Fan KY; Liu HC
    Clin Neuropharmacol; 2017; 40(3):152-153. PubMed ID: 28452902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 17. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram.
    Markowitz JS; DeVane CL; Liston HL; Montgomery SA
    Int Clin Psychopharmacol; 2000 Nov; 15(6):329-33. PubMed ID: 11110008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors.
    Strachan J; Shepherd J
    Aust N Z J Psychiatry; 1998 Apr; 32(2):295-8. PubMed ID: 9588311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin syndrome caused by interaction between citalopram and fentanyl.
    Ailawadhi S; Sung KW; Carlson LA; Baer MR
    J Clin Pharm Ther; 2007 Apr; 32(2):199-202. PubMed ID: 17381671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.